Individual patient data meta-analysis in cancer

Area of Science:

• Oncology
• Biostatistics
• Public Health

Background:

• Cancer treatment effects can be moderately different, impacting major endpoints like survival.
• Identifying these moderate differences is vital for public health, especially in prevalent cancers.
• Large-scale randomized evidence is necessary to reliably investigate these subtle yet significant differences.

Purpose of the Study:

• To illustrate the importance of meta-analyses using individual patient data in cancer research.
• To present the first comprehensive list of individual patient data meta-analysis projects in oncology.
• To highlight the value of this research methodology for advancing cancer care.

Main Methods:

• Conducting meta-analyses of updated, centrally collected individual patient data from all relevant randomized cancer trials.
• Utilizing large-scale randomized evidence to reliably detect moderate differences in treatment effects.
• Compiling a comprehensive list of ongoing and completed individual patient data meta-analysis projects.

Main Results:

• Individual patient data meta-analyses are a powerful tool for investigating moderate differences in cancer treatment efficacy.
• Such research provides reliable evidence for informing public health decisions in oncology.
• The paper offers a valuable resource by listing existing and past individual patient data meta-analysis projects.

Conclusions:

• Meta-analyses of individual patient data are essential for advancing cancer treatment understanding.
• This methodology reliably identifies moderate treatment effects, benefiting public health.
• The provided list serves as a crucial reference for researchers and clinicians in the field of oncology.